Pay in 4 interest-free payments of $6.34 Learn more
Ships within 48 hours · Estimated delivery Aug 23 - Aug 28
CrossRef Case Report: Serum AKR1B10 as a complementary marker for the detection of AFP-negative hepatocellular carcinoma a report of two cases Ye Gao, Lihua Xie, Yuting Ou, Xi Zeng, Deliang Cao, Jianping Yin Frontiers in Medicine .2026;[Epub] CrossRef Liver Stiffness Measured by Vibration-Controlled Transient Elastography Predicts Hepatic Decompensation in Patients with Hepatocellular Carcinoma Receiving Systemic Treatments Jaejun Lee, Hyun Yang, Si Hyun Bae, Hee Sun Cho, Pil Soo Sung, Jeong Won Jang, Seung Kew Yoon, Keungmo Yang, Heechul Nam, Chang Wook Kim, Hae Lim Lee, Hee Yeon Kim, Sung Won Lee, Ahlim Lee, Do Seon Song, Seok Hwan Kim, Myung Jun Song, Soon Kyu Lee, Jung H Liver Cancer .2026
This predictability speeds treatment starts, but insurance reimbursement isnt guaranteed when you pay cash
Read more: Samsung Biologics Buys PolyPeptide in $1.81 Billion Deal to Enter GLP-1 Drug Manufacturing A Notable Corporate Detail: Two Approvals, One Parent Company Among the five newly registered products, two Seemasun (Sun Farmacutica do Brasil) and Orsema (Ranbaxy Farmacutica) belong to subsidiaries of the same parent corporation: Sun Pharmaceutical Industries, India's largest specialty pharmaceutical company by revenue
Lower calories
US$ 27.74
US$ 22.59
US$ 24.23
US$ 29.83
US$ 20.26
US$ 25.05
US$ 29.03
